Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.

NCT01863511 is registered in ClinicalTrials.gov with The Christ Hospital as lead sponsor.

NCT NCT01863511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01863511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.
Lead sponsor
The Christ Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2015
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure